Roivant Sciences Ltd. buy BiotechBee
Start price
24.06.23
/
60%
€9.00
Target price
31.12.25
€16.00
Performance (%)
25.44%
End price
14.12.24
€11.29
Summary
This prediction ended on 14.12.24 with a price of €11.29. The prediction had a final performance of 25.44%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Roivant Sciences Ltd. | - | - | - |
| iShares Core DAX® | 2,49 % | -5,94 % | 2,90 % |
| iShares Nasdaq 100 | 1,65 % | -2,46 % | 15,75 % |
| iShares Nikkei 225® | 0,55 % | -7,60 % | 30,35 % |
| iShares S&P 500 | 1,35 % | -2,94 % | 10,34 % |
According to BiotechBee what are the pros and cons of Roivant Sciences Ltd. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year